SELANK

Selank is believed to exert its effects by modulating the balance of neurotransmitters in the central nervous system—particularly by enhancing the activity of serotonin, dopamine, and GABA pathways. It may also upregulate brain-derived neurotrophic factor (BDNF) expression, supporting neuroplasticity and cognitive function. Additionally, Selank has shown activity in immune modulation, possibly influencing cytokine expression and stress resilience.
Safety Profile
Preclinical studies and limited human trials suggest that Selank is well-tolerated with a strong safety profile. No significant toxicity, sedation, or withdrawal symptoms have been reported. It has been used in research contexts without the risks associated with benzodiazepines or traditional anxiolytics, making it of interest in long-term cognitive and stress-related studies.
Key Studies
Russian studies have documented reduced anxiety-like behavior in rodents, improved learning and memory, and enhanced resistance to stress.
Clinical evaluations in patients with generalized anxiety and cognitive fatigue demonstrated improved mental clarity, decreased irritability, and enhanced concentration.
Research has also explored its synergistic potential when combined with Semax or other neuropeptides.
Conclusion
Selank is a promising neuropeptide for research in the fields of anxiety modulation, cognitive enhancement, and immune-neuroendocrine interaction. Its multifunctional profile, low toxicity, and non-sedating nature make it an attractive compound for laboratories studying mental health, neurological resilience, and stress response. Selank is intended for laboratory research use only and is not for human consumption.